Edmond DE Rothschild Holding S.A. Invests $7.39 Million in CME Group Inc. $CME

Posted by Francis Steltz on Aug 20th, 2026

Edmond DE Rothschild Holding S.A. bought a new stake in CME Group Inc. (NASDAQ:CME – Free Report) in the second quarter, Holdings Channel reports. The institutional investor bought 33,467 shares of the financial services provider’s stock, valued at approximately $7,391,000.

Several other institutional investors and hedge funds have also modified their holdings of the business. Whipplewood Advisors LLC increased its holdings in CME Group by 2,075.0% during the 1st quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 83 shares in the last quarter. Elkhorn Partners Limited Partnership acquired a new position in CME Group in the fourth quarter worth $27,000. Hilton Head Capital Partners LLC acquired a new position in CME Group in the fourth quarter worth $28,000. Mowery & Schoenfeld Wealth Management LLC bought a new stake in shares of CME Group during the second quarter worth $28,000. Finally, Legacy Wealth Managment LLC ID grew its holdings in shares of CME Group by 191.9% during the fourth quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider’s stock worth $29,000 after purchasing an additional 71 shares during the last quarter. 87.75% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other CME Group news, Director William R. Shepard bought 325 shares of CME Group stock in a transaction dated Thursday, June 25th. The shares were bought at an average price of $230.57 per share, with a total value of $74,935.25. Following the purchase, the director owned 260,442 shares of the company’s stock, valued at $60,050,111.94. This trade represents a 0.12% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Company insiders own 0.30% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on CME. JPMorgan Chase & Co. raised their target price on CME Group from $249.00 to $250.00 and gave the company an “underweight” rating in a research note on Thursday, July 23rd. Keefe, Bruyette & Woods raised shares of CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 price objective on the stock in a report on Thursday, June 18th. Rothschild & Co Redburn upgraded shares of CME Group from a “neutral” rating to a “buy” rating and raised their price objective for the company from $316.00 to $323.00 in a research report on Thursday, June 11th. Barclays dropped their target price on shares of CME Group from $316.00 to $270.00 and set an “equal weight” rating for the company in a research note on Thursday, July 9th. Finally, Raymond James Financial reiterated an “outperform” rating and set a $320.00 target price on shares of CME Group in a research report on Thursday, July 2nd. Nine analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $288.56.

View Our Latest Report on CME

CME Group Trading Down 1.7%

CME stock opened at $266.94 on Thursday. The company has a market cap of $95.99 billion, a P/E ratio of 22.64, a PEG ratio of 3.16 and a beta of 0.23. CME Group Inc. has a twelve month low of $218.31 and a twelve month high of $329.16. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. The business has a fifty day moving average of $250.89 and a 200-day moving average of $279.81.

CME Group (NASDAQ:CME – Get Free Report) last issued its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.91 by $0.08. The business had revenue of $1.71 billion for the quarter, compared to analyst estimates of $1.68 billion. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The firm’s revenue for the quarter was up .8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.96 earnings per share. As a group, equities research analysts expect that CME Group Inc. will post 12.27 EPS for the current year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 25th. Shareholders of record on Wednesday, September 9th will be given a dividend of $1.30 per share. The ex-dividend date is Wednesday, September 9th. This represents a $5.20 dividend on an annualized basis and a yield of 1.9%. CME Group’s dividend payout ratio is presently 44.11%.

CME Group Company Profile

(Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.